SB142 - Preserve Access to Affordable Generics and Biosimilars Act
US Congress - 118th Congress
Introduced byAmy Klobuchar, Chuck Grassley, Richard Durbin
Last updated over 1 year ago
11 Co-Sponsors
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now